keflex
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.00 | $60.07 (0%) | 🛒 Add to cart |
| 90 | $0.96 | $90.10 $86.10 (4%) | 🛒 Add to cart |
| 120 | $0.93 | $120.14 $111.13 (7%) | 🛒 Add to cart |
| 180 | $0.90 | $180.21 $162.19 (10%) | 🛒 Add to cart |
| 270 | $0.88 | $270.31 $238.27 (12%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $360.41 $317.36 (12%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.17 | $70.08 (0%) | 🛒 Add to cart |
| 90 | $1.11 | $105.12 $100.12 (5%) | 🛒 Add to cart |
| 120 | $1.09 | $140.16 $131.15 (6%) | 🛒 Add to cart |
| 180 | $1.07 | $210.24 $193.22 (8%) | 🛒 Add to cart |
| 270 | $1.05 | $315.36 $283.33 (10%) | 🛒 Add to cart |
| 360 | $1.04
Best per pill | $420.48 $374.43 (11%) | 🛒 Add to cart |
Similar products
Cephalexin, marketed under the brand name Keflex among others, is a first-generation cephalosporin antibiotic belonging to the beta-lactam class. It’s a bactericidal agent that interferes with bacterial cell wall synthesis, making it particularly effective against a range of Gram-positive and some Gram-negative organisms. In clinical practice, we’ve been using cephalexin for decades—it’s one of those workhorse antibiotics that every clinician should have in their toolkit, though its utility has evolved with changing resistance patterns.
Keflex: Comprehensive Antibiotic Treatment for Bacterial Infections - Evidence-Based Review
1. Introduction: What is Keflex? Its Role in Modern Medicine
Keflex represents one of the older cephalosporins that somehow maintains relevance despite the antibiotic resistance crisis. What is Keflex used for? Primarily, we’re talking about skin and soft tissue infections, respiratory tract infections, urinary tract infections, and bone infections caused by susceptible organisms. The interesting thing about Keflex is that while newer antibiotics have emerged, this drug continues to have its place because of its predictable pharmacokinetics and generally favorable safety profile.
I remember when I first started prescribing Keflex back in the late 90s—we used it for everything from strep throat to cellulitis. The landscape has changed significantly since then, but the drug remains surprisingly useful in selected cases. What many younger clinicians don’t appreciate is that Keflex was actually derived from cephalosporin C, which was isolated from a fungus found in sewage near Sardinia—quite the humble origins for such a clinically important compound.
2. Key Components and Bioavailability of Keflex
The active pharmaceutical ingredient in Keflex is cephalexin monohydrate, which is rapidly absorbed after oral administration. The bioavailability of Keflex is approximately 90% under fasting conditions, though food can delay absorption without significantly reducing the total amount absorbed. This is actually quite important clinically—I’ve had patients who experienced GI upset when taking it on an empty stomach, so we often recommend taking it with food despite the slight delay in peak concentrations.
The chemical structure features a beta-lactam ring that’s essential for its antibacterial activity, plus dihydrothiazine and various side chains that determine its spectrum. Unlike some antibiotics that require complex dosing regimens, the composition of Keflex allows for relatively straightforward q6-12h dosing depending on the indication and severity.
What’s interesting from a pharmacological perspective is that despite being acid-stable (unlike some early penicillins), we still see variable absorption between patients. I had one patient—Mrs. G, 72 with diabetic neuropathy—who needed higher than usual doses to achieve therapeutic levels, likely due to delayed gastric emptying from her autonomic neuropathy.
3. Mechanism of Action of Keflex: Scientific Substantiation
So how does Keflex work exactly? The mechanism involves binding to penicillin-binding proteins (PBPs) on the bacterial cell membrane, which inhibits the transpeptidation step of cell wall synthesis. This leads to activation of autolytic enzymes that literally digest the bacterial cell wall. The result is bactericidal activity against susceptible organisms.
The science behind this is actually quite elegant—the beta-lactam ring structurally mimics the D-alanyl-D-alanine portion of the peptidoglycan precursor, essentially tricking the bacteria into incorporating a faulty component into their cell wall. It’s like giving a construction crew defective bricks and watching the wall collapse.
Where Keflex really shines is against Gram-positive organisms like Staphylococcus aureus (excluding MRSA), Streptococcus pyogenes, and Streptococcus pneumoniae. The coverage extends to some Gram-negatives like E. coli, Klebsiella, and Proteus mirabilis, though resistance has increased over time. I’ve found that understanding the precise mechanism helps explain why we see treatment failures in certain scenarios—like when bacterial load is exceptionally high or when there’s poor tissue penetration.
4. Indications for Use: What is Keflex Effective For?
Keflex for Skin and Soft Tissue Infections
For uncomplicated cellulitis and skin infections, Keflex remains a reasonable first-line option when we’re confident we’re dealing with streptococcal species or methicillin-sensitive Staph aureus. The key is proper wound culture before initiation when possible. I recently treated a construction worker, Mark, 38, who presented with cellulitis after a minor abrasion—Keflex cleared it within 5 days with excellent results.
Keflex for Respiratory Tract Infections
In community-acquired pneumonia and other respiratory infections, Keflex can be effective against susceptible pneumococci and Group A strep, though its utility has diminished with increasing resistance patterns. We need to be particularly careful here—I’ve seen several cases where presumed strep throat turned out to be viral, leading to unnecessary antibiotic exposure.
Keflex for Urinary Tract Infections
For uncomplicated UTIs caused by E. coli, Proteus, or Klebsiella, Keflex can be effective, though resistance rates have climbed significantly. We recently analyzed our clinic data and found only about 60% of E. coli isolates remain susceptible to cephalexin in our community.
Keflex for Bone and Joint Infections
In osteomyelitis caused by susceptible organisms, Keflex can be used following initial IV therapy, though we typically reserve it for less severe cases. The bone penetration is moderate—around 10-20% of serum levels—which is why we often need higher doses for these infections.
5. Instructions for Use: Dosage and Course of Administration
The dosage of Keflex varies significantly based on the infection being treated, patient factors, and local resistance patterns. Here’s a general framework:
| Indication | Adult Dose | Frequency | Duration |
|---|---|---|---|
| Skin/soft tissue infections | 250-500 mg | Every 6 hours | 7-14 days |
| Respiratory infections | 250 mg | Every 6 hours | 7-14 days |
| Uncomplicated UTIs | 250 mg | Every 6 hours | 7 days |
| Bone infections | 500 mg | Every 6 hours | 4-6 weeks |
For pediatric patients, we typically use 25-50 mg/kg/day divided every 6-8 hours, not to exceed adult dosing.
The course of administration should be completed even if symptoms improve earlier—this is crucial for preventing recurrence and resistance development. I can’t emphasize this enough based on my experience with non-adherent patients who stop after 2-3 days because they “feel better,” only to return with a more resistant infection.
6. Contraindications and Drug Interactions with Keflex
The main contraindication for Keflex is known hypersensitivity to cephalosporins. There’s about 5-10% cross-reactivity with penicillin allergies, so we need to be cautious in those patients. I generally avoid Keflex in patients with immediate-type hypersensitivity to penicillins.
Important drug interactions include:
- Probenecid: Can increase cephalexin concentrations by reducing renal clearance
- Metformin: May increase metformin levels slightly
- Oral contraceptives: Potential reduced efficacy—recommend backup contraception
In terms of safety during pregnancy, Keflex is Category B—generally considered safe, though we still exercise caution, especially in the first trimester. For breastfeeding mothers, small amounts are excreted in milk, but it’s usually compatible with nursing.
The side effects are typically mild—GI symptoms like diarrhea, nausea, and occasional vomiting. More serious adverse effects like pseudomembranous colitis, hypersensitivity reactions, and transient liver enzyme elevations can occur but are less common.
7. Clinical Studies and Evidence Base for Keflex
The evidence for Keflex dates back to the 1970s, with numerous studies establishing its efficacy. A 2018 systematic review in Clinical Infectious Diseases found that for uncomplicated skin infections, cephalexin demonstrated clinical cure rates of 85-92% in randomized trials.
More recent research has focused on its role in the context of antimicrobial stewardship. A 2021 study in JAMA Network Open found that for uncomplicated cellulitis, cephalexin was non-inferior to broader-spectrum alternatives when combined with proper wound care and follow-up.
What the literature doesn’t always capture is the real-world effectiveness—like the case of Mr. Henderson, 65, with recurrent folliculitis who failed multiple newer antibiotics but responded beautifully to a 14-day course of Keflex. Sometimes the older drugs just work better for certain patients, though we’re still trying to understand why.
8. Comparing Keflex with Similar Products and Choosing Quality
When comparing Keflex to other antibiotics, several factors come into play:
Versus amoxicillin: Keflex has better staphylococcal coverage but less activity against enterococci and H. influenzae.
Versus clindamycin: Keflex lacks coverage against anaerobes but has a better GI side effect profile.
Versus newer cephalosporins: Second and third-generation agents have expanded Gram-negative coverage but often at higher cost and broader ecological impact.
The choice between brand name Keflex and generic cephalexin mainly comes down to cost and patient preference—the bioequivalence is well-established. What matters more is selecting the right antibiotic for the specific clinical scenario based on local resistance patterns and individual patient factors.
9. Frequently Asked Questions (FAQ) about Keflex
What is the recommended course of Keflex to achieve results?
The typical duration ranges from 7 days for simple UTIs to 4-6 weeks for bone infections. Completing the full course is essential regardless of symptom improvement.
Can Keflex be combined with other medications?
Keflex can interact with probenecid and may reduce effectiveness of oral contraceptives. Always inform your provider about all medications you’re taking.
Is Keflex effective against MRSA?
No, Keflex is not effective against methicillin-resistant Staphylococcus aureus (MRSA) due to altered penicillin-binding proteins in resistant strains.
Can Keflex be taken during pregnancy?
Keflex is generally considered safe during pregnancy (Category B), but should only be used when clearly needed and under medical supervision.
What should I do if I miss a dose of Keflex?
Take the missed dose as soon as you remember, unless it’s almost time for your next dose. Never double dose to make up for a missed one.
10. Conclusion: Validity of Keflex Use in Clinical Practice
Despite being one of the older cephalosporins, Keflex maintains an important place in our antimicrobial arsenal when used judiciously. The risk-benefit profile remains favorable for appropriate indications, particularly skin and soft tissue infections caused by susceptible organisms.
The key is thoughtful patient selection and awareness of local resistance patterns. As antibiotic stewardship becomes increasingly crucial, drugs like Keflex that have a narrow spectrum and established safety profile may see renewed importance in our fight against antimicrobial resistance.
I was thinking about Sarah, a patient I’ve treated for recurrent UTIs over the past three years. We’d tried multiple antibiotics, but she kept having recurrences every few months. Last year, during one particularly stubborn episode, her culture showed E. coli that was resistant to everything except—surprisingly—cephalexin. We used a 10-day course followed by postcoital prophylaxis, and she’s been infection-free for eight months now. Sometimes the simplest solutions work best, even when we’re tempted to reach for newer, fancier options.
What’s interesting is that our infectious disease team had a heated debate just last month about whether we should remove Keflex from our outpatient guidelines entirely. The data from our microbiology lab showed declining susceptibility rates, but when we looked at actual treatment outcomes, patients who received Keflex for appropriate indications did just as well as those on broader-spectrum drugs, with fewer side effects and lower cost. We ultimately decided to keep it but with stricter criteria for use.
The longitudinal follow-up with patients like Sarah reinforces that sometimes the older drugs, when used wisely, still have an important role. It’s not about having the newest weapon in our arsenal—it’s about knowing when to deploy the right one.